STOCK TITAN

[Form 4] UNITEDHEALTH GROUP INCORPORATED (Delaware) Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

UnitedHealth Group Inc. (UNH) filed a Form 4 on 26-Jun-2025 detailing a minor insider transaction by Timothy J. Noel, Chief Executive Officer of UnitedHealthcare (a principal subsidiary).

On 24-Jun-2025, Noel acquired 47.823 shares of UNH common stock at $0.00 per share. The acquisition represents dividend-equivalent units automatically credited on outstanding restricted stock units (RSUs); these units carry the same vesting schedule as the underlying RSUs and will be forfeited if the RSUs do not vest. Following the credit, Noel’s direct beneficial ownership increased to 9,243.999 shares.

No open-market purchases, option exercises, or cash transactions occurred, and there was no use of a Rule 10b5-1 trading plan. The filing is procedural in nature, recording routine dividend accruals rather than an active investment decision by the insider.

UnitedHealth Group Inc. (UNH) ha presentato un Modulo 4 il 26 giugno 2025, riportando una piccola operazione interna effettuata da Timothy J. Noel, Amministratore Delegato di UnitedHealthcare (una controllata principale).

Il 24 giugno 2025, Noel ha acquisito 47.823 azioni ordinarie UNH a 0,00 $ per azione. L'acquisizione rappresenta unità equivalenti a dividendi automaticamente accreditate su unità azionarie vincolate (RSU) in essere; queste unità seguono lo stesso piano di maturazione delle RSU sottostanti e saranno perse se le RSU non maturano. Dopo l'accredito, la proprietà diretta effettiva di Noel è aumentata a 9.243,999 azioni.

Non si sono verificati acquisti sul mercato aperto, esercizi di opzioni o transazioni in contanti, né è stato utilizzato un piano di trading secondo la Regola 10b5-1. La comunicazione ha carattere procedurale, registrando accantonamenti di dividendi di routine piuttosto che una decisione attiva di investimento da parte dell'insider.

UnitedHealth Group Inc. (UNH) presentó un Formulario 4 el 26 de junio de 2025 detallando una pequeña transacción interna realizada por Timothy J. Noel, Director Ejecutivo de UnitedHealthcare (una subsidiaria principal).

El 24 de junio de 2025, Noel adquirió 47.823 acciones ordinarias de UNH a $0.00 por acción. La adquisición representa unidades equivalentes a dividendos acreditadas automáticamente sobre unidades restringidas de acciones (RSU) en circulación; estas unidades tienen el mismo calendario de adquisición que las RSU subyacentes y se perderán si las RSU no se consolidan. Tras el abono, la propiedad directa beneficiaria de Noel aumentó a 9,243.999 acciones.

No hubo compras en el mercado abierto, ejercicios de opciones ni transacciones en efectivo, y no se utilizó un plan de negociación según la Regla 10b5-1. La presentación es de carácter procedimental, registrando acumulaciones rutinarias de dividendos en lugar de una decisión activa de inversión por parte del insider.

UnitedHealth Group Inc.(UNH)는 2025년 6월 26일, UnitedHealthcare(주요 자회사)의 최고경영자 Timothy J. Noel의 소규모 내부자 거래를 상세히 기재한 Form 4를 제출했습니다.

2025년 6월 24일, Noel은 UNH 보통주 47,823주를 주당 0.00달러에 취득했습니다. 이 취득은 미결 제한 주식 단위(RSU)에 자동으로 적립된 배당금 상당 단위로, 이 단위들은 기초 RSU와 동일한 베스팅 일정이 적용되며 RSU가 베스트되지 않으면 몰수됩니다. 적립 후 Noel의 직접 소유 지분9,243.999주로 증가했습니다.

시장 내 개별 매수, 옵션 행사 또는 현금 거래는 없었으며, Rule 10b5-1 거래 계획도 사용하지 않았습니다. 이번 제출은 내부자의 적극적인 투자 결정이 아닌 일상적인 배당 적립을 기록하는 절차적인 성격입니다.

UnitedHealth Group Inc. (UNH) a déposé un formulaire 4 le 26 juin 2025 détaillant une transaction interne mineure réalisée par Timothy J. Noel, directeur général de UnitedHealthcare (une filiale principale).

Le 24 juin 2025, Noel a acquis 47 823 actions ordinaires UNH à 0,00 $ par action. Cette acquisition correspond à des unités équivalentes de dividendes automatiquement créditées sur des unités d’actions restreintes (RSU) en circulation ; ces unités suivent le même calendrier d’acquisition que les RSU sous-jacentes et seront perdues si les RSU ne sont pas acquises. Après ce crédit, la possession directe bénéficiaire de Noel est passée à 9 243,999 actions.

Aucun achat sur le marché ouvert, exercice d’options ou transaction en espèces n’a eu lieu, et aucun plan de négociation conforme à la règle 10b5-1 n’a été utilisé. Le dépôt est de nature procédurale, enregistrant des accumulations de dividendes de routine plutôt qu’une décision d’investissement active de l’initié.

UnitedHealth Group Inc. (UNH) reichte am 26. Juni 2025 ein Formular 4 ein, das eine kleinere Insider-Transaktion von Timothy J. Noel, CEO von UnitedHealthcare (einer Haupttochtergesellschaft), detailliert beschreibt.

Am 24. Juni 2025 erwarb Noel 47.823 Aktien der UNH-Stammaktien zu 0,00 $ pro Aktie. Der Erwerb stellt dividendenäquivalente Einheiten dar, die automatisch auf ausstehenden Restricted Stock Units (RSUs) gutgeschrieben werden; diese Einheiten unterliegen dem gleichen Vesting-Zeitplan wie die zugrunde liegenden RSUs und verfallen, wenn die RSUs nicht vesten. Nach der Gutschrift erhöhte sich Noels direktes wirtschaftliches Eigentum auf 9.243,999 Aktien.

Es fanden keine Käufe am offenen Markt, keine Ausübung von Optionen oder Bartransaktionen statt, und es wurde kein Rule 10b5-1 Handelsplan verwendet. Die Meldung ist prozeduraler Natur und erfasst routinemäßige Dividendengutschriften, nicht jedoch eine aktive Investitionsentscheidung des Insiders.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine dividend-equivalent credit; immaterial to UNH valuation or insider sentiment.

The Form 4 shows a non-cash addition of 47.823 shares tied to RSU dividend equivalents. Such credits are common and signal neither bullish nor bearish intent. Noel’s total holdings rise marginally to ~9.2k shares, a tiny fraction of UNH’s 928 m fully diluted shares outstanding. Because the units remain subject to RSU vesting, there is no immediate liquidity impact. From a market perspective, the transaction is neutral and provides no incremental insight into future operating performance.

TL;DR: Administrative insider filing; reflects standard equity compensation mechanics, not governance concern.

This filing complies with Section 16 reporting rules, evidencing transparency around equity-based pay. The absence of a Rule 10b5-1 designation confirms the credit occurred automatically under the RSU plan. No red flags emerge regarding timing, volume, or pricing. The event neither alters insider control dynamics nor suggests governance risk. Overall, the impact on shareholders’ oversight considerations is minimal.

UnitedHealth Group Inc. (UNH) ha presentato un Modulo 4 il 26 giugno 2025, riportando una piccola operazione interna effettuata da Timothy J. Noel, Amministratore Delegato di UnitedHealthcare (una controllata principale).

Il 24 giugno 2025, Noel ha acquisito 47.823 azioni ordinarie UNH a 0,00 $ per azione. L'acquisizione rappresenta unità equivalenti a dividendi automaticamente accreditate su unità azionarie vincolate (RSU) in essere; queste unità seguono lo stesso piano di maturazione delle RSU sottostanti e saranno perse se le RSU non maturano. Dopo l'accredito, la proprietà diretta effettiva di Noel è aumentata a 9.243,999 azioni.

Non si sono verificati acquisti sul mercato aperto, esercizi di opzioni o transazioni in contanti, né è stato utilizzato un piano di trading secondo la Regola 10b5-1. La comunicazione ha carattere procedurale, registrando accantonamenti di dividendi di routine piuttosto che una decisione attiva di investimento da parte dell'insider.

UnitedHealth Group Inc. (UNH) presentó un Formulario 4 el 26 de junio de 2025 detallando una pequeña transacción interna realizada por Timothy J. Noel, Director Ejecutivo de UnitedHealthcare (una subsidiaria principal).

El 24 de junio de 2025, Noel adquirió 47.823 acciones ordinarias de UNH a $0.00 por acción. La adquisición representa unidades equivalentes a dividendos acreditadas automáticamente sobre unidades restringidas de acciones (RSU) en circulación; estas unidades tienen el mismo calendario de adquisición que las RSU subyacentes y se perderán si las RSU no se consolidan. Tras el abono, la propiedad directa beneficiaria de Noel aumentó a 9,243.999 acciones.

No hubo compras en el mercado abierto, ejercicios de opciones ni transacciones en efectivo, y no se utilizó un plan de negociación según la Regla 10b5-1. La presentación es de carácter procedimental, registrando acumulaciones rutinarias de dividendos en lugar de una decisión activa de inversión por parte del insider.

UnitedHealth Group Inc.(UNH)는 2025년 6월 26일, UnitedHealthcare(주요 자회사)의 최고경영자 Timothy J. Noel의 소규모 내부자 거래를 상세히 기재한 Form 4를 제출했습니다.

2025년 6월 24일, Noel은 UNH 보통주 47,823주를 주당 0.00달러에 취득했습니다. 이 취득은 미결 제한 주식 단위(RSU)에 자동으로 적립된 배당금 상당 단위로, 이 단위들은 기초 RSU와 동일한 베스팅 일정이 적용되며 RSU가 베스트되지 않으면 몰수됩니다. 적립 후 Noel의 직접 소유 지분9,243.999주로 증가했습니다.

시장 내 개별 매수, 옵션 행사 또는 현금 거래는 없었으며, Rule 10b5-1 거래 계획도 사용하지 않았습니다. 이번 제출은 내부자의 적극적인 투자 결정이 아닌 일상적인 배당 적립을 기록하는 절차적인 성격입니다.

UnitedHealth Group Inc. (UNH) a déposé un formulaire 4 le 26 juin 2025 détaillant une transaction interne mineure réalisée par Timothy J. Noel, directeur général de UnitedHealthcare (une filiale principale).

Le 24 juin 2025, Noel a acquis 47 823 actions ordinaires UNH à 0,00 $ par action. Cette acquisition correspond à des unités équivalentes de dividendes automatiquement créditées sur des unités d’actions restreintes (RSU) en circulation ; ces unités suivent le même calendrier d’acquisition que les RSU sous-jacentes et seront perdues si les RSU ne sont pas acquises. Après ce crédit, la possession directe bénéficiaire de Noel est passée à 9 243,999 actions.

Aucun achat sur le marché ouvert, exercice d’options ou transaction en espèces n’a eu lieu, et aucun plan de négociation conforme à la règle 10b5-1 n’a été utilisé. Le dépôt est de nature procédurale, enregistrant des accumulations de dividendes de routine plutôt qu’une décision d’investissement active de l’initié.

UnitedHealth Group Inc. (UNH) reichte am 26. Juni 2025 ein Formular 4 ein, das eine kleinere Insider-Transaktion von Timothy J. Noel, CEO von UnitedHealthcare (einer Haupttochtergesellschaft), detailliert beschreibt.

Am 24. Juni 2025 erwarb Noel 47.823 Aktien der UNH-Stammaktien zu 0,00 $ pro Aktie. Der Erwerb stellt dividendenäquivalente Einheiten dar, die automatisch auf ausstehenden Restricted Stock Units (RSUs) gutgeschrieben werden; diese Einheiten unterliegen dem gleichen Vesting-Zeitplan wie die zugrunde liegenden RSUs und verfallen, wenn die RSUs nicht vesten. Nach der Gutschrift erhöhte sich Noels direktes wirtschaftliches Eigentum auf 9.243,999 Aktien.

Es fanden keine Käufe am offenen Markt, keine Ausübung von Optionen oder Bartransaktionen statt, und es wurde kein Rule 10b5-1 Handelsplan verwendet. Die Meldung ist prozeduraler Natur und erfasst routinemäßige Dividendengutschriften, nicht jedoch eine aktive Investitionsentscheidung des Insiders.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Noel Timothy John

(Last) (First) (Middle)
C/O UNITEDHEALTH GROUP INCORPORATED
1 HEALTH DRIVE

(Street)
EDEN PRAIRIE MN 55344

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer, UHC
3. Date of Earliest Transaction (Month/Day/Year)
06/24/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/24/2025 A 47.823(1) A $0 9,243.999 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest.
Remarks:
Faraz A. Choudhry, Attorney-in-Fact for Timothy J. Noel 06/26/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Timothy J. Noel acquire in the latest UNH Form 4 filing?

47.823 shares of UNH common stock, credited as dividend equivalents on existing RSUs.

Was cash paid for the 47.823 UNH shares reported on 24-Jun-2025?

No. The shares were credited at $0.00 as part of RSU dividend equivalents.

How many UNH shares does Noel own after the transaction?

He now directly holds 9,243.999 shares.

Does the filing indicate use of a Rule 10b5-1 trading plan?

No. The corresponding checkbox was left blank.

Are the credited dividend equivalents immediately vested?

No. They carry the same vesting terms as the underlying RSUs and could be forfeited.
Unitedhealth Gp

NYSE:UNH

UNH Rankings

UNH Latest News

UNH Latest SEC Filings

UNH Stock Data

273.97B
904.46M
0.24%
90.3%
0.95%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
EDEN PRAIRIE